NIKA — NIKA PHARMACEUTICALS, INC
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1145604 ·
Last close
$0.35
Market Cap
$369.14M
52W High
$0.98
52W Low
$0.20
ADV30
153
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 0 | — | -13,023 | -13,023 | 5,309 | 352 | 349,014 |
| Jun 2026 | 0 | — | -19,694 | -19,694 | 9,942 | 2,932 | 340,624 |
| Mar 2026 | 0 | — | -13,359 | -13,359 | 20,637 | 1,530 | 331,624 |
| Dec 2025 | 0 | — | -37,088 | -37,089 | 20,996 | 1,889 | 318,624 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-70,785
Investing CF
$0
Financing CF
$64,850
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-9,050,086
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-83,164
Pretax Income TTM
$-83,165
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -76,398 | -76,398 | 20,996 | 318,624 | -297,628 | -79,654 |
| Dec 2024 | 0 | -95,792 | -95,792 | 17,934 | 239,164 | -221,230 | -154,932 |
| Dec 2023 | 0 | -64,833 | -64,833 | 19,596 | 101,745 | -82,149 | -64,833 |
| Dec 2022 | 0 | -3,183,715 | -3,183,715 | 864 | 18,180 | -17,316 | -33,715 |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-78,125
OpCashFlow TTM
—
Assets (Latest)
$9,942
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PBYI | PUMA BIOTECHNOLOGY, INC. | $369.13M | $7.14 | — |
| SPRY | ARS Pharmaceuticals, Inc. | $366.93M | $3.65 | — |
| CRMD | CorMedix Inc. | $371.44M | $4.67 | — |
| CYDY | CytoDyn Inc. | $366.64M | $0.25 | — |
| PEPG | PepGen Inc. | $365.73M | $3.88 | — |
News headlines (Yahoo Finance, 1h cache)
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) Funding Update
2026-08-25 14:13 · Yahoo
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) June 2026 Update
2026-06-04 14:10 · Yahoo
Nika Pharmaceuticals, Inc. (NIKA) Signed a Consultancy Agreement with MD Global Partners LLC
2026-03-06 16:58 · Yahoo
Nika Pharmaceuticals, Inc. (NIKA) Progress Update
2025-12-03 16:58 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.